Practical Health Co-operation - The Impact of a Referral Template on Quality of Health Care

July 10, 2014 updated by: University Hospital of North Norway

Practical Health Co-operation - a Randomised Controlled Intervention Study. The Impact of a Referral Template on Quality of Care and Health Care Co-operation Between Primary and Secondary Care

The purpose of this study is to examine whether the implementation of a referral template will increase quality of health care delivered and the quality of health care co-operation. The investigators intent to implement a referral template, at the level of the general practitioner (GP), for the referral of patients within 4 separate diagnostic groups:

  • dyspepsia/upper GI symptoms
  • colonic cancer investigation/lower GI symptoms
  • chronic obstructive pulmonary disease (COPD)
  • chest pain

Local GP clinics will be randomised to use the referral template or to use standard referral practice. Using a predefined set of quality criteria the investigators will score the process of care in each patient, and compare intervention and control groups. In addition other criteria will be collected and compared between the two groups, e.g.

  • time to diagnosis/treatment
  • quality of referral
  • more appropriate referrals
  • patient satisfaction (as measured by a questionnaire)

The investigators hypothesize that the implementation of a referral template will lead to a measurable increase in the quality of health care delivered.

Study Overview

Status

Completed

Detailed Description

There is a continuous work to improve the quality of health care delivered to an individual patient, both in primary and secondary care. The referral from primary to secondary care represents a key component in the communication between the levels of care, and therefore an important tool in developing the quality of care. There has been many attempts at improving the quality of referrals, but less work has been focussed on the consequence of such improvement on quality of health care. This study is designed as a randomised controlled intervention study where we intent to implement a referral templates, at the level of the general practitioner (GP). These templates will be for the referral of patients within 4 separate diagnostic groups:

  • dyspepsia/upper GI symptoms
  • colonic cancer investigation/lower GI symptoms
  • chronic obstructive pulmonary disease (COPD)
  • chest pain

Following the course of the health care process we will assess the quality of the care process by using predefined quality of care criteria, together with patient satisfaction (as measured by questionnaire) and other health process indicators.

Our primary hypothesis is that the implementation of a referral template in the communication between primary and secondary care, will lead to a measurable increase in the quality of health care delivered.

Secondary hypothesis include:

  • the use of a referral template in the communication between the GP and secondary care, will lead to better patient satisfaction.
  • the use of a referral template in the communication between the GP and secondary care, will lead to a change (up or down) in the amount of patients defined as being in need of prioritisation (as defined pr. national guidelines for prioritisation in health care)
  • the use of a referral template in the communication between the GP and secondary care, will lead to a measurable referral quality improvement
  • the use of a referral template in the communication between the GP and secondary care, will increase the "appropriateness" of the referrals

Study Type

Interventional

Enrollment (Actual)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Harstad, Norway, 9480
        • Medical department - University Hospital of North Norway Harstad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • referral to medical department of University Hospital of North Norway, Harstad

Exclusion Criteria:

  • children (< 18 years of age)
  • patients with reduced capacity to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Referral template
Implementation of the referral templates at the GP office
Implementation of referral template at the GP office
No Intervention: Control
Normal referral pattern

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collated quality indicator score
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
Based on treatment guidelines and international quality assessment tools we have developed quality indicators score sets for each of the 4 diagnostic groups in the study. The scores will be compared between intervention and control GP offices to assess the effect of the referral template.
The care period for each patient (approx. 3 weeks up to 1 year)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improved referral quality
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
The investigators will evaluate each referral against the referral template, and then compare between intervention and control groups.
The care period for each patient (approx. 3 weeks up to 1 year)
Waiting time from referral to appointment
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
The care period for each patient (approx. 3 weeks up to 1 year)
Time from referral to initiation of treatment
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
Compare the time from referral to initiation of treatment/"decision no treatment" necessary between intervention and control groups
The care period for each patient (approx. 3 weeks up to 1 year)
Percentage of patients seen within investigation deadline
Time Frame: Assessed at end of study - approx 2 years
Compare the number of patients in the two groups seen within the limit set in national prioritisation guidelines
Assessed at end of study - approx 2 years
Number of patients designated with investigation deadline
Time Frame: Assessed at end of study - approx 2 years
Compare the number of patients in the intervention vs. control group that were designated with a investigation deadline according to national prioritisation guidelines
Assessed at end of study - approx 2 years
Patient satisfaction
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
Patient satisfaction as measured by self report questionnaire
The care period for each patient (approx. 3 weeks up to 1 year)
Positive predictive value of referral
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)

Compare the percentage of referrals between the intervention and control groups which have lead to

  1. a diagnostic clarification, or
  2. a histological diagnosis, or
  3. a change in medical management
The care period for each patient (approx. 3 weeks up to 1 year)
Number of appointments needed for diagnostic clarification
Time Frame: The care period for each patient (approx. 3 weeks up to 1 year)
Compare the number of appointments needed to clarify diagnosis between intervention and control groups
The care period for each patient (approx. 3 weeks up to 1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ann Ragnhild Broderstad, Dr. med, University Hospital of North Norway

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

September 5, 2011

First Submitted That Met QC Criteria

November 10, 2011

First Posted (Estimate)

November 11, 2011

Study Record Updates

Last Update Posted (Estimate)

July 11, 2014

Last Update Submitted That Met QC Criteria

July 10, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • HST1026-11

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Health Care

Clinical Trials on Implementation of referral template

Subscribe